Alaunos Therapeutics (TCRT) Net Equity Issued and Repurchased (2010 - 2023)
Alaunos Therapeutics' Net Equity Issued and Repurchased was $92,000 in FY2023, down 99.4% from $14.72 million in FY2022.
Analysis
Alaunos Therapeutics (TCRT) Net Equity Issued and Repurchased (2010 - 2023) Analysis & Trends
From FY2009 onward, Alaunos Therapeutics has reported Net Equity Issued and Repurchased for 15 years.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -17.5% (FY2018 to FY2023).
- The FY2023 figure marks the lowest annual Net Equity Issued and Repurchased in data going back to FY2009.
- Per Business Quant data, Net Equity Issued and Repurchased in earlier years was $14.72 million in FY2022, $1.04 million in FY2021 (+134.4%), $442,000 in FY2020 (-99.2%) and $52.5 million in FY2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 43.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 9.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Alaunos Therapeutics | 2.24 Mn | -1.56 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 92,000.00 |
| Dec 31, 2022 | 14.70 Mn |
| Sep 30, 2022 | 21,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Jun 30, 2021 | 19,000.00 |
| Mar 31, 2021 | 1.02 Mn |
| Dec 31, 2020 | 399,000.00 |
| Sep 30, 2020 | 27,000.00 |
| Jun 30, 2020 | 12,000.00 |
| Mar 31, 2020 | 4,000.00 |
| Dec 31, 2019 | 51.48 Mn |
| Sep 30, 2019 | 420,000.00 |
| Jun 30, 2017 | 47.24 Mn |
| Mar 31, 2017 | 29,000.00 |
| Dec 31, 2016 | 163,000.00 |
| Jun 30, 2016 | 184,000.00 |
| Mar 31, 2016 | 367,000.00 |
| Mar 31, 2015 | 94.32 Mn |
| Dec 31, 2014 | 6.90 Mn |
API Access
Alaunos Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=TCRT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "TCRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=TCRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();